Diagnostics and therapy of paediatric patients with febrile neutropenia
-
Published:2023-12
Issue:
Volume:2
Page:100116
-
ISSN:2772-610X
-
Container-title:EJC Paediatric Oncology
-
language:en
-
Short-container-title:EJC Paediatric Oncology
Author:
Koenig ChristaORCID,
Lehrnbecher ThomasORCID
Reference115 articles.
1. Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment);Hough;Hematol. Am. Soc. Hematol. Educ. Program,2017
2. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort;Essig;Lancet Oncol.,2014
3. The influence of different fever definitions on the rate of fever in neutropenia diagnosed in children with cancer;Ammann;PLoS One,2015
4. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation;Castagnola;Clin. Infect. Dis.,2007
5. A.H. Groll, D. Pana, F. Lanternier, A. Mesini, R.A. Ammann, D. Averbuch, et al., 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation, Lancet Oncol., 22, 2021, pp. e254–e269.